Pharmafile Logo

AstraZeneca launches diabetes portal in Germany

Zuckerkrank.de is designed to educate patients and families

zuckerkrank_de_start_astrazeneca

AstraZeneca has launched a new online portal for patients and families to learn about living with type 2 diabetes.

Zuckerkrank.de has information on treatment options and outlines how type 2 diabetes patients can use exercise and diet to improve the likelihood of successful treatment.

Visitors to the site can download a nutrition guide, for example. This includes examples of food labelled according to the traffic light system.

Tips and practical advice for everyday life with type 2 diabetes are also available, as well as a range of materials and advice from experts. Other features of the portal include information on treatment options and individual treatment levels.

Topics covered include diabetes and mental health, and separate sections on the site outline diabetes-related events and links to other useful information sources.

Patients will also find information on diabetes care during pregnancy, and how best to maintain their blood sugar levels when travelling, for example.

Advice is also given on how to manage careers while coping with type 2 diabetes and its symptoms. The site explains, for instance, whether sufferers are obliged to disclose the condition when applying for jobs, and lists roles unsuited to people at risk from hypoglycaemia.

Type 2 diabetes is a priority area for AstraZeneca and the company’s Diabetic Initiative in Germany aims to inform people about the disease while supporting those affected. The new portal is the first step in this awareness campaign.

Article by Tom Meek
19th August 2014
From: Marketing
Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links